Literature DB >> 21271664

Fanconi-Bickel syndrome: report of life history and successful pregnancy in an affected patient.

Loren Pena1, Joel Charrow.   

Abstract

Fanconi–Bickel syndrome (FBS, OMIM #227810) is a rare autosomal recessive disorder of carbohydrate transport originally described in 1949 [Fanconi and Bickel(1949);Helv Paediatr Acta 4: 359–396]. FBS is caused by mutations in the glucose and galactose transporter gene SLC2A2 (HGNC ID11006) [Santeret al.(1997); Nat Genet 17: 324–326] and is characterized by hepatic glycogen accumulation with hepatomegaly, fasting hypoglycemia, short stature, impaired glucose tolerance, hyperlipidemia, and tubular nephropathy. Although the described complications would not seem to preclude fertility in FBS patients, there has been no report of reproduction in affected individuals to date. We have followed a female with FBS for at least 20 years. She received a clinical diagnosis in adolescence, with recent molecular confirmation of two mutations in trans in the SLC2A2 gene. She has had glucosuria, proteinuria, impaired tubular reabsorption of phosphate, osteopenia, and hypercholesterolemia throughout her life, without any documented episodes of hypoglycemia. Hepatomegaly was initially noticed in infancy and resolved in late adolescence. She became pregnant at 31 years of age, had gestational diabetes treated with diet, and delivered a healthy boy. She had impaired glucose tolerance after her pregnancy.Her adult height was at the lower end of her target height range, and she had evidence of localized osteopenia at the left distal radius on DXA scan. This report describes the clinical history of an affected individual and highlights the importance of continued follow-up in order to extend our understanding of the history of this rare metabolic disorder.
© 2011 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21271664     DOI: 10.1002/ajmg.a.33822

Source DB:  PubMed          Journal:  Am J Med Genet A        ISSN: 1552-4825            Impact factor:   2.802


  8 in total

1.  Fanconi-Bickel syndrome as an example of marked allelic heterogeneity.

Authors:  Mohammad Al-Haggar
Journal:  World J Nephrol       Date:  2012-06-06

2.  Phenotypic variability in patients with fanconi-bickel syndrome with identical mutations.

Authors:  Elena Fridman; Avraham Zeharia; Tal Markus-Eidlitz; Yishai Haimi Cohen
Journal:  JIMD Rep       Date:  2014-04-10

3.  Case Report: Fanconi-Bickel Syndrome in a Chinese Girl With Diabetes and Severe Hypokalemia.

Authors:  Hongbo Chen; Juan-Juan Lyu; Zhuo Huang; Xiao-Mei Sun; Ying Liu; Chuan-Jie Yuan; Li Ye; Dan Yu; Jin Wu
Journal:  Front Pediatr       Date:  2022-06-09       Impact factor: 3.569

4.  The Successful Anesthetic Management of a Cesarean Delivery in a Patient with Fanconi-Bickel Syndrome.

Authors:  Alexander M DeLeon; Rishi D Gaiha; Feyce M Peralta
Journal:  Case Rep Anesthesiol       Date:  2022-07-08

5.  Fanconi-Bickel Syndrome: Two Pakistani Patients Presenting with Hypophosphatemic Rickets.

Authors:  Bushra Afroze; Margaret Chen
Journal:  J Pediatr Genet       Date:  2016-06-03

6.  Mutations in SLC2A2 gene reveal hGLUT2 function in pancreatic β cell development.

Authors:  Aurélien Michau; Ghislaine Guillemain; Alexandra Grosfeld; Sandrine Vuillaumier-Barrot; Teddy Grand; Mathilde Keck; Sébastien L'Hoste; Danielle Chateau; Patricia Serradas; Jacques Teulon; Pascale De Lonlay; Raphaël Scharfmann; Edith Brot-Laroche; Armelle Leturque; Maude Le Gall
Journal:  J Biol Chem       Date:  2013-08-28       Impact factor: 5.157

7.  Fanconi-Bickel syndrome in an infant with cytomegalovirus infection: A case report and review of the literature.

Authors:  Li-Jing Xiong; Mao-Ling Jiang; Li-Na Du; Lan Yuan; Xiao-Li Xie
Journal:  World J Clin Cases       Date:  2020-11-06       Impact factor: 1.337

Review 8.  Fanconi-Bickel Syndrome: A Review of the Mechanisms That Lead to Dysglycaemia.

Authors:  Sanaa Sharari; Mohamad Abou-Alloul; Khalid Hussain; Faiyaz Ahmad Khan
Journal:  Int J Mol Sci       Date:  2020-08-31       Impact factor: 5.923

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.